Professional Summary

Professional Overview

Ralph Tiedt is an accomplished VP of Oncology with extensive experience in the pharmaceutical and biotech industry. He possesses deep expertise in oncology translational research, target and drug discovery, and oncology drug discovery. Tiedt is currently leading oncology initiatives at Monte Rosa Therapeutics and the Novartis Institutes for BioMedical Research.

Experience Summary

Current Role

As the VP of Oncology at Monte Rosa Therapeutics, Tiedt is responsible for driving the company's oncology research and development efforts. In this capacity, he oversees all aspects of oncology translational research, including target identification, preclinical candidate selection, and clinical development strategy. Tiedt also serves as the Senior Director of Target and Drug Discovery at Monte Rosa, where he leads a team of scientists in the discovery of novel oncology targets and the development of innovative therapeutic agents.

Concurrently, Tiedt holds the position of Associate Director in Oncology Translational Research at the Novartis Institutes for BioMedical Research. In this role, he collaborates with cross-functional teams to advance the company's oncology pipeline, leveraging his expertise in target and drug discovery to identify and validate new therapeutic opportunities.

Career Progression

Prior to his current roles, Tiedt spent several years as a (Senior) Investigator in Oncology Drug Discovery at the Novartis Institutes for BioMedical Research. In this position, he made significant contributions to the development of novel oncology therapies, leading to the advancement of multiple clinical candidates.

Tiedt began his career as a Postdoctoral Fellow at the University Hospital Basel, where he conducted cutting-edge research in the field of oncology and gained valuable experience in translational medicine.

Academic Background

Tiedt holds a Ph.D. in Molecular Biology from a leading Swiss university, with a specialization in oncology research. His doctoral work focused on the identification and characterization of novel cancer targets, laying the foundation for his subsequent career in the pharmaceutical and biotech industries.

Areas of Expertise

• Oncology translational research

• Target and drug discovery

• Oncology drug discovery

• Preclinical and clinical development strategy

• Cross-functional collaboration

• Project management and team leadership

Professional Impact

Tiedt has made significant contributions to the advancement of oncology research and development throughout his career. His work has led to the identification of several novel oncology targets and the development of promising therapeutic candidates, contributing to the industry's efforts to improve patient outcomes in this critical disease area.

Conclusion

With his extensive experience, strong technical expertise, and proven leadership skills, Ralph Tiedt is a valuable asset to the pharmaceutical and biotech industry. As he continues to drive innovation and progress in oncology research, Tiedt is well-positioned to make a lasting impact on the field and contribute to the development of life-changing cancer therapies.